Search Results 871-880 of 19790 for Receptor
The purpose of this study is to determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker ...
This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor ... The second aim of this study is to sequence the TCR receptors of ...
Hormone receptor status: Estrogen or progesterone receptor positive as defined by tumor receptor content at least 10 fmol/mg protein or receptor positive ...
... receptor-1/Programmed Death receptor Ligand-1 (anti-PD-1/PD-L1) therapy; Cohort B: Participants with locally advanced unresectable or metastatic/recurrent ...
Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. J Nucl Med. 2026 Jan ...
The case fatality rate is probably about 10 times higher than influenza. This particular virus is very efficiently adapted to find those receptors, bind tightly ...
... receptor (MC1R) is being evaluated as a monotherapy and in combination with Nivolumab in subjects with unresectable and metastatic melanoma. Participation ...
Incretin-modifying agents, including glucagon-like peptide-1 (GLP-1) receptor agonists, are emerging as the most promising drug treatments for obesity ...
"At the same time, the heart sends signals back to the brain through nerves, hormones, and pressure receptors — affecting our mood, attention, and stress levels ...
that selective estrogen receptor modulators (SERM) therapy with tamoxifen and raloxifene can lower a woman's risk for developing breast cancer. However ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.